Compare Avantis International Small Cap Value ETF (AVDV) vs Illumina, Inc. (ILMN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Avantis International Small Cap Value ETF vs Illumina, Inc. — how do they compare? Avantis International Small Cap Value ETF trades at $105.24, while Illumina, Inc. trades at $192.3 (market cap $28.93B). The key difference: Illumina, Inc. is trading nearer its 52-week high, Avantis International Small Cap Value ETF nearer its low. Which is the better fit depends on your goals.
| AVDV | ILMN | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $110.40 | $194.33 |
52-Week Low | $80.02 | $91.00 |
Market Cap | — | $28.93B |
Enterprise Value | — | $30.32B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Avantis International Small Cap Value ETF
AVDV is an actively managed ETF that targets small-cap value companies in developed markets outside the United States. It uses a systematic, rules-based process to identify firms trading at low valuations with high profitability, aiming to capture the 'size' and 'value' premiums while maintaining broad diversification.
Read more on AVDV →About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →
